ASPN ASPEN AEROGELS INC

ASPN financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1145986 Exchange: NYSE SIC: 5030 (Wholesale-Lumber & Other Construction Materials) Latest filing: 10-Q filed Aug 7, 2026 Data checked: Oct 21, 2026
Showing 3 of 14 annual and 0 of 52 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Accelerated filer
Entity Type
Operating
Public Float
$480.00M (Jun 2025)
Industry (SIC)
5030 Wholesale-Lumber & Other Construction Materials
Incorporated
DE
Fiscal Year End
December (1231)
Phone
5086911111
EIN
043559972
Headquarters
NORTHBOROUGH, MA, 01532
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$202.09M
Net Income
$-126.20M
Total Assets
$392.94M
Total Equity
$192.46M
Total Debt
$80.32M
Free Cash Flow
$34.38M
Ratios
Gross Margin
2.7%
Operating Margin
-61%
Net Margin
-62.4%
Return on Equity
-65.6%
Return on Assets
-32.1%
Current Ratio
2.52x
Debt / Equity
0.42x
FCF / Assets
8.7%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

In fiscal 2025, ASPEN AEROGELS INC recorded $271.10M of revenue, net loss of $389.55M, and an operating cash inflow of $32.87M. Revenue of $271.10M sets the scale for evaluating how effectively sales translated into profit and cash during the year. Revenue was 40.1% below fiscal 2024 revenue of $452.70M, marking a top-line contraction. The company reported diluted EPS of -$4.73, adding a shareholder-level measure to the absolute income figures considered below. Total assets stood at $406.68M, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Revenue equaled 0.67x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

The first profit layer was $46.00M of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross profit represented 17.0% of revenue, showing how much of the top line remained after direct costs. Operations produced a $378.23M operating loss before non-operating and tax effects. Relative to revenue, the operating deficit measured 139.5%, showing the shortfall after operating costs. The company ended the period with a net loss of $389.55M, extending the operating result through all remaining items. Measured against revenue, the bottom-line deficit represented 143.7% after all recognized items. The company reported a pretax loss of $387.16M, before the effect of income taxes. Measured against revenue, the pretax deficit represented 142.8%. The company recognized $2.39M of income tax for the period, completing the transition from pretax income to net income. The net loss equaled 165.4% of period-end equity, showing the deficit relative to book capital. The net loss equaled 95.8% of period-end assets, showing the deficit relative to the asset base.

Liquidity and Capital Structure

At period end, the $406.68M asset base was financed through $171.16M of liabilities and $235.52M of equity. At period end, current assets of $242.05M compared with current liabilities of $62.02M, defining the company’s short-term resource position. At 3.9x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. The company held $156.86M in cash and equivalents, a narrower liquidity measure than total current assets. The cash balance equaled 252.9% of current liabilities, showing how much near-term coverage came from cash alone. Borrowings totaled $90.57M, adding a fixed financing obligation alongside the company’s equity capital. The debt-to-equity relationship was 0.38x, showing how much debt the company carried for each unit of book equity. Relative to total assets, debt measured 22.3%, showing how much of the asset base was matched by borrowing. Relative to total assets, liabilities measured 42.1%, complementing the separate equity-based view of the company’s capital structure. Measured against total assets, cash and equivalents represented 38.6%, a balance-sheet composition measure rather than a liquidity forecast. Total assets were 54.6% lower than fiscal 2024 assets of $895.14M, measuring the company’s own balance-sheet change. Book equity was 61.7% lower than fiscal 2024 equity of $614.71M, showing how shareholder capital changed year over year.

Cash Flow and Earnings Quality

Cash flow from operations was $32.87M, a reported cash inflow that can be compared directly with net income and capital spending. The cash-flow statement records $37.45M of capital expenditures, the investment amount considered after operating cash generation. Capital spending absorbed 113.9% of operating cash flow, quantifying the share of cash from operations directed to investment. The company recorded a $4.58M cash deficit after capital spending for the period. The free-cash-flow deficit equaled 1.7% of revenue, showing the post-investment cash shortfall relative to sales. The cash deficit after capital spending represented 1.1% of the period-end asset base.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for ASPEN AEROGELS INC
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $271.10M $452.70M $238.72M
Cost of Revenue $225.11M $269.80M $181.80M
Gross Profit $46.00M $182.90M $56.92M
OPERATING EXPENSES
R&D Expense $13.42M $18.05M $16.36M
SG&A Expense $55.77M $71.13M $56.76M
Other Operating Expenses (derived) $355.04M $39.19M $33.01M
Operating Income $-378.23M $54.54M $-49.20M
NON-OPERATING INCOME / EXPENSE
Other Income/Expense $-8.93M $-39.45M $3.39M
Pretax Income $-387.16M $15.09M $-45.81M
Income Tax $2.39M $1.71M $0
Net Income $-389.55M $13.38M $-45.81M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-4.73 $0.17 $-0.66
Diluted Shares 82.33M 80.31M 69.44M
EBITDA $-333.07M $77.06M $-33.89M
Depreciation & Amortization $45.16M $22.53M $15.32M
Balance Sheet
ASSETS
Cash & Equivalents $156.86M $220.88M $139.72M
Accounts Receivable $35.27M $109.10M $70.00M
Inventory $38.25M $47.55M $39.19M
Other Current Assets $9.96M $31.52M $17.18M
Current Assets $242.05M $409.45M $266.33M
PP&E (Net) $98.40M $459.28M $417.23M
Other Noncurrent Assets $9.37M $5.57M $2.28M
Noncurrent Assets $164.63M $485.70M $436.72M
Total Assets $406.68M $895.14M $703.05M
LIABILITIES
Accounts Payable $13.24M $44.36M $51.09M
Short-term Debt $25.12M $19.75M -
Other Current Liabilities $10.02M $17.12M $5.94M
Current Liabilities $62.03M $110.11M $78.10M
Long-term Debt $65.46M $94.96M -
Other Noncurrent Liabilities (derived) $43.68M $75.37M -
Noncurrent Liabilities $109.14M $170.33M $136.90M
Total Liabilities $171.16M $280.44M $214.99M
EQUITY
Common Stock $0 $0 $0
Additional Paid-in Capital $1.29B $1.27B $1.16B
Retained Earnings $-1.05B $-660.23M $-673.60M
Total Equity $235.52M $614.71M $488.06M
Total Liabilities & Equity $406.68M $895.14M $703.05M
SUPPLEMENTAL
Total Debt $90.57M $114.71M -
Shares Outstanding 82.71M 82.04M 76.50M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $32.87M $45.55M $-42.61M
Capital Expenditures $37.45M $86.26M $175.46M
Cash from Investing $-37.45M $-86.26M $-175.46M
Cash from Financing $-58.13M $122.02M $75.48M
Free Cash Flow $-4.58M $-40.71M $-218.07M
Beginning Cash (CFS) $221.28M $139.97M $282.56M
Net Change in Cash $-62.71M $81.31M $-142.59M
Effect of FX on Cash - - -
Calculated Ending Cash $158.57M $221.28M $139.97M
Cash per BS $156.86M $220.88M $139.72M
Cash scope difference (CFS − BS) $1.71M $394.00K $248.00K
Cash per CFS $158.57M $221.28M $139.97M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is ASPEN AEROGELS INC's annual revenue?

ASPEN AEROGELS INC reported $202.09M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is ASPEN AEROGELS INC profitable?

No. ASPEN AEROGELS INC reported $-126.20M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

What is ASPEN AEROGELS INC's debt level?

ASPEN AEROGELS INC carries $80.32M in total debt as of trailing twelve months. Total shareholders' equity stands at $192.46M.

Does ASPEN AEROGELS INC generate free cash flow?

Yes. Free cash flow was $34.38M for trailing twelve months. Operating cash flow was $49.12M.